Alf Gunnar Martin Nicklasson is a Swedish businessperson who has been the head of 11 different companies. Presently, he is Chairman for Zealand Pharma A, Non-Executive Chairman of Kymab Ltd., Chairman for Sanivo Pharma AS and Chairman for Farma Investment AS.
He is also Member of The Royal Bachelors' Club, Member of Royal Swedish Academy of Engineering Sciences, Member of Swedish Academy For Pharmaceutical Sciences, Senior Partner at Nicklasson Life Science AB and Associate Professor at the University of Uppsala and on the board of 5 other companies.
He previously occupied the position of Chairman for Orexo AB, President & Chief Executive Officer of Swedish Orphan Biovitrum AB President & Chief Executive Officer of Biovitrum AB and Chief Executive Officer of Swedish Orphan International Holding AB (both are subsidiaries of Swedish Orphan Biovitrum AB), Chief Executive Officer of Astra Hässle AB and EVP-Product Strategy & Business Development at AstraZeneca Plc and Chief Executive Officer at AstraZeneca AB (a subsidiary of AstraZeneca Plc).
Alf Gunnar Martin Nicklasson received a graduate degree and a doctorate from the University of Uppsala.